Drug Database
DI

diclofenac (Topfan / Dolaut)

✓ Approved

Therabel · PTGS1 · 小分子

什么是 diclofenac?

diclofenac 是一种小分子,由Therabel研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Topfan, Dolaut
公司Therabel
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Topical
状态Approved

作用机制

分子靶点

diclofenac 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

diclofenac 针对 3 个适应症,涉及 3 个治疗领域。

治疗领域疾病/病症分期
Gastrointestinal disordersAbdominal pain✓ Approved
Hepatobiliary disordersHepatitis✓ Approved
Musculoskeletal and connective tissue disordersMusculoskeletal pain✓ Approved

相关研究文献

PubMedJFMS open reports2026-11-18

Use of subconjunctival cyclosporine implants for treatment of feline eosinophilic keratoconjunctivitis: A case report.

Willems Lynn L, Roberts Jordan K JK

A 5-year-old, neutered male domestic shorthair cat was presented for evaluation of chronic bilateral eosinophilic keratoconjunctivitis (EK). The patient had a history of recurrent corneal plaques and conjunctivitis that were initially managed with systemic and topical immunosuppressive therapy. Long-term disease control was limited by poor tolerance of topical ophthalmic medications, resulting in inconsistent treatment and repeated disease recurrence affecting both eyes. Over several years, the cat was treated with subconjunctival triamcinolone acetonide, antiviral therapy, and topical megestrol acetate, with only partial and temporary improvement. As a result of persistent disease and inability to administer long-term topical therapy reliably, bilateral subconjunctival cyclosporine implants were surgically placed. Postoperative management included short-term topical antibiotic therapy. At 10-week and 7-month postoperative examinations, marked clinical improvement was observed, with resolution of most corneal plaques and substantial reduction in conjunctival inflammation. Feline EK is a chronic immune-mediated ocular surface disease that typically requires long-term topical immunosuppressive therapy. Successful management may be limited in patients who are resistant to medication administration. This case demonstrates that subconjunctival cyclosporine implants may represent a viable long-acting treatment option for feline EK when topical therapy cannot be consistently administered. To the authors' knowledge, the use of cyclosporine implants for the management of feline EK has not previously been reported.

PMID 43048052
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Low-Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double-Blind, Double-Dummy Controlled Trial.

Chaudhry Muhammad Asad Ejaz MAE, Muneeb Bushra B, Aamir Safoora S, Saeed Zoha Arif ZA et al.

Androgenetic alopecia (AGA) is a prevalent, progressive condition with significant psychosocial impact. Current pharmacological modalities like topical minoxidil and finasteride have limitations. Low-dose oral minoxidil has surfaced as a valid off-label solution, with the practical advantage of once-daily dosing. To evaluate the efficacy and safety of topical and oral minoxidil in AGA. In this double-blind, double-dummy randomized controlled trial, 100 patients aged 18-50 years with AGA were randomized to receive either twice-daily topical minoxidil (5% in males, 2% in females) plus a placebo tablet, or once-daily oral minoxidil (2.5 mg in males, 1.25 mg in females) plus a placebo spray for 6 months. The primary outcome was the proportion of patients achieving ≥ +1 improvement in a validated 7-point global photographic scale. Secondary outcomes included patient satisfaction and adverse effects. Data were analyzed using SPSS v26 with p ≤ 0.05 as significant. Ninety patients completed 24 weeks of follow-up. Photographic assessment demonstrated that mild-to-excellent improvement (≥ +1) occurred in both the oral (67%) and topical minoxidil (73%) groups (p = 0.652). Patient-reported satisfaction was high in both groups (topical: 70.5%; oral: 80.4%, p = 0.332), with a non-significant trend favoring oral minoxidil at the moderate satisfaction threshold (58.7% vs. 38.6%, p = 0.057). Median improvement scores were comparable between groups for both clinician assessment and patient-reported outcomes. Hypertrichosis was significantly more frequent with oral minoxidil (30% vs. 9%, p = 0.011), whereas contact dermatitis was exclusive to topical minoxidil (11% vs. 0%, p = 0.025). No serious adverse events were observed. Both topical and low-dose oral minoxidil demonstrated clinically meaningful improvement in androgenetic alopecia. Despite oral therapy exhibiting a trend toward higher patient satisfaction, this study was not powered to establish non-inferiority or equivalence. The dermatologist-assessed outcomes indicated no significant intergroup differences. Low-dose oral minoxidil may be considered a practical alternative in selected patients, particularly where adherence to topical therapy is limited. ClinicalTrials.gov: NCT07273799.

PMID 43047224
阅读全文 →
PubMedBMC complementary medicine and therapies2026-11-18

Salvia willeana (Holmboe) Hedge extract as a natural dual-action agent: anti-inflammatory and antimicrobial synergy.

Oduncuoglu Goksu G, Şanlıtürk Gizem G

Salvia comprises valuable species are rich in phenolic compounds and possess medicinal activities. Salvia willeana (Holmboe) Hedge is known as Troodos sage, endemic to Cyprus and has strong antiseptic activity. This study investigates the potential synergistic anti-inflammatory effects of S. willeana extract combined with non-steroidal anti-inflammatory agents and evaluates the extract's enhancement of antimicrobial activity of selected antibiotics against Methicillin-resistant Staphylococcus aureus (MRSA). The phenolic compounds of methanol extract from S. willeana were investigated by means of LC-MS/MS. Anti-inflammatory activity of the extract (30-300 µg/mL) was evaluated alone and in combination with diclofenac sodium through the protein denaturation inhibition assay. The antimicrobial activity of S. willeana extract against MRSA (ATCC 33591) was investigated using microdilution assay. A checkerboard assay was performed to evaluate the combinatory effect of the extract in combination with different antibiotics against MRSA. For statistical analysis, one-way ANOVA, post hoc Tukey's multiple comparisons test and chi-square test were used. Twenty-two phenolic compounds in S. willeana methanol extract were detected and rosmarinic acid and jaceosidin were found as the major compounds. The total phenolic and flavonoid contents were calculated as 314.98 ± 11.67 mg GAE/g and 156.30 ± 7.39 mg QE/g dry extract, respectively. S. willeana methanol extract showed concentration-dependent anti-inflammatory activity. Furthermore, the extract has a lower IC50 (109.4 µg/mL) relative to standard diclofenac sodium (434.0 µg/mL). The combination of S. willeana extract and diclofenac sodium showed a synergistic interaction since the experimental IC50 (Zexp = 14.90 µg/mL) was lower than the theoretical (Zadd = 271.7 µg/mL). MIC and MBC of S. willeana extract against MRSA were determined as 125 µg/mL. The combination of β-lactam (ampicillin, cefazolin) and aminoglycoside (kanamycin, streptomycin) antibiotics with the extract resulted in synergistic interactions (FICI < 0.5) whereas, the combination of chloramphenicol with the extract showed an indifferent effect (FICI = 2.0). The dual anti-inflammatory and antimicrobial activity of S. willeana extract highlight its potential for the treatment of inflammatory bacterial infections.

PMID 43046015
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Mechanistic Review of Topical Therapies Targeting Dermal Fibroblasts in Skin Aging and Rejuvenation.

Akaberi Seyedeh Melika SM, Esfandiyari Mohammad M, Ahmadi Ashtiani Hamid Reza HR

Skin aging appears in multiple forms, including wrinkles, sagging, scarring, atrophy, and photoaging. Although each phenotype has distinct biological features, all are rooted in dermal fibroblast dysfunction. This review examines the molecular pathways underlying these conditions and evaluates topical interventions designed to restore skin integrity. To assess how dermal fibroblast dysfunction contributes to different skin aging phenotypes and to evaluate topical therapies targeting the underlying molecular mechanisms. A narrative review of the literature was conducted focusing on fibroblast-related molecular pathways and topical interventions used for skin aging and rejuvenation. UVB radiation contributes to wrinkle formation by activating collagen-degrading enzymes in the upper dermis, whereas sagging results from UVA-induced damage to deeper connective tissues and altered fat distribution. Scarring is characterized by excessive fibroblast activation and extracellular matrix overproduction, while atrophy develops through fibroblast senescence and loss of structural support. Photoaging involves oxidative stress and elastin disorganization caused by chronic ultraviolet exposure. Topical agents including retinol, niacinamide, caffeine, asiaticoside, and related compounds stimulate collagen synthesis, reduce matrix degradation, and protect fibroblasts from oxidative damage. Unlike previous reviews that examine skin aging as a single process, this review compares distinct aging phenotypes through the common framework of fibroblast dysfunction and their associated molecular targets. Dermal fibroblast dysfunction is a central mechanism underlying multiple forms of skin aging. Targeting fibroblast-related pathways with topical therapies may address the biological causes of wrinkles, sagging, scarring, atrophy, and photoaging, supporting more personalized and effective skin rejuvenation strategies.

PMID 43047057
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Peptides as Cosmeceuticals for Post-Procedural Wound Healing: A Systematic Review.

Padmanabhan Reethi R, Gill Connor C, Joerg Lucie L, Motlak Miriam M et al.

Topical peptides have emerged as a promising cosmeceutical for indications ranging from hyperpigmentation to anti-aging. However, their role in post-procedural wound healing following aesthetic interventions remains underexplored. The aim of this study was to systematically evaluate the evidence supporting the use of topical peptide formulations in enhancing post-procedural wound healing and patient recovery outcomes. A systematic review was conducted to identify clinical studies evaluating topical peptide application following aesthetic dermatologic procedures, including radiofrequency microneedling and non-ablative laser therapies. Eligible studies assessed both cosmetic and therapeutic outcomes related to wound healing and recovery. Six studies met inclusion criteria across three peptide systems and across ablative laser, nonablative laser, hybrid laser, and radiofrequency microneedling procedures. Peptide formulations following ablative procedures were associated with improvements in exudation, crusting, and epithelial confluence, whereas nonablative procedures demonstrated reduced erythema and improved patient-reported recovery outcomes, including enhanced skin appearance and texture. Studies of hybrid fractional resurfacing and radiofrequency microneedling similarly reported improvements in selected early recovery outcomes. Topical peptide formulations show potential as adjunctive therapies for improving post-procedural recovery following aesthetic dermatologic procedures. However, available evidence is limited by varying procedural modalities, small sample sizes, short follow-up intervals, and restricted demographic diversity. Larger randomized controlled trials with broader representation across Fitzpatrick skin types are necessary to better define the clinical role of topical peptide cosmeceuticals in post-procedural wound healing.

PMID 43047393
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Prospective, Double-Blind, Vehicle-Controlled Assessment of Topical Bakuchiol on Photoaging in a Chinese Population.

Khan Zill-E-Human ZE, Chaudhuri Ratan K RK, Dulai Ajay A, Tarmaster Anurag A et al.

Aging skin is a universal complaint among diverse patient populations. It encompasses physiologic changes to the skin, such as skin laxity, dyspigmentation, fine lines, and wrinkles. However, different populations may show different signs of aged skin. For example, Asian skin in particular exhibits stronger dyspigmentation in comparison to Caucasian skin. There has been a growing interest in using bakuchiol as an alternative to retinoids in treating the appearance of aging skin. This study explores how topical bakuchiol can improve the appearance of aging skin in a Chinese population. This study evaluates the effects of topical bakuchiol on markers of aging skin, such as wrinkle severity, dyspigmentation, radiance, and pore size. In this 84-day study, 73 participants were randomized to receive either topical bakuchiol or a placebo. Participants were evaluated at five visits: Baseline, Day 28, Day 56, and Day 84. Facial photography and analysis were performed. Clinical grading assessed wrinkle severity, hyperpigmentation, skin radiance, and pore appearance. Tolerability was assessed. There was a significant reduction in wrinkle severity, hyperpigmentation, pore size, and improved radiance in the Bakuchiol group compared to the vehicle group in a Chinese population of women and men at days 24, 52, and 84. The use of topical bakuchiol improved the appearance of wrinkle severity, hyperpigmentation, skin radiance, and pore size in a Chinese population.

PMID 43047082
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多diclofenac